[1] |
Ferris FL III, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol,1982,94:91-96.
|
[2] |
Csaky KG, Richman EA, Ferris FL 3rd. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci,2008,49:479-489.
|
[3] |
Dong LM, Hawkins BS, Marsh MJ. Consistency Between Visual Acuity Scores Obtained at Different Test Distances. Arch Ophthalmol,2002,120:1523-1533.
|
[4] |
Ferris FL 3rd, Bailey I. Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum. Ophthalmology,1996,103:181-182.
|
[5] |
Falkenstein IA, Cochran DE, Azen SP, et al. Comparison of visual acuity in macular degeneration patients measured with Snellen and Early Treatment Diabetic Retinopathy Study Charts. Ophthalmology,2008,115:319-323.
|
[6] |
Elliott DB, Sheridan M. The use of accurate visual acuity measurements in clinical anti-cataract formulation trials. Ophthalmic Physiol Opt,1988,8:397-401.
|
[7] |
Raasch TW, Bailey IL, Bullimore MA. Repeatability of visual acuity measurement. Optom Vis Sci,1998,75:342-348.
|
[8] |
Kiser AK, Mladenovich D, Eshraghi F, et al. Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease. Optom Vis Sci,2005,82:946-954.
|
[9] |
Patel PJ, Chen FK, Rubin GS, et al. Intersession Repeatability of Visual Acuity Scores in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci,2008,49:4347-4352.
|
[10] |
Leinonen J, Laakkonen E, Laatikainen L. Random measurement error in visual acuity measurements in clinical settings. Acta Ophthalmol Scand,2005,83:328-332.
|
[11] |
Manny RE, Hussein M, Gwiazda J, et al. Repeatability of ETDRS visual acuity in children. Invest Ophthalmol Vis Sci,2003,44:3294-3300.
|
[12] |
Rosser DA, Laidlaw DA, Murdoch IE. The development of a ″reduced logMAR″ visual acuity chart for use in routine clinical practice. Br J Ophthalmol,2001,85:432-436.
|
[13] |
Laidlaw DA, Abbott A, Rosser DA. Development of clinically feasible logMAR alternatives to the Snellen chart: performance of the ″compact reduced logMAR″ visual acuity chart in amblyopic children. Br J Ophthalmol,2003,87:1232-1234.
|
[14] |
Patel PJ, Bunce C, Tufail A. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin (R) (bevacizumab) intravitreal injections compared to standard therapy in subjectswith choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design. Trials,2008,9:56.
|
[15] |
Tufail A, Patel PJ, Egan C, et al. Bevacizumab for neovascular age-related macular degeneration (ABC Trial): multicentre randomiseddouble masked study. BMJ,2010,340:c2459.
|
[16] |
Lim LA, Frost NA, Powell RJ, et al. Comparison of the ETDRS logMAR, compact reduced logMar and Snellen charts in routine clinical practice. Eye (Lond),2010,24:673-677.
|
[17] |
Camparini M, Cassinari P, Ferrigno L, et al. ETDRS-fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Invest Ophthalmol Vis Sci,2001,42:1226-1231.
|